Sarepta Therapeutics Stock Predictions

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

Sell

SRPT
Sarepta Therapeutics

Last Price:

$17.43

Seasonality Move:

17.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Notable investors are buying this "unlisted" stock

Sarepta Therapeutics Stock Forecast

Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 47.3% based on the past 28 years of stock performance.
Sarepta Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Is Sarepta Therapeutics Stock Undervalued?

The current Sarepta Therapeutics [SRPT] share price is $17.46. The Score for SRPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sarepta Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 47.3% based on the past 28 years of stock performance.

Sarepta Therapeutics Stock Rating

Sell

Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics overpriced?

Sarepta Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Sarepta Therapeutics Stock Price History

Is SRPT stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

sarepta.com

52-Week Data

52-Week High:

162.95

52-Week Low:

17.00

Prediction Charts

Market Cap:

1.7B

Price in USD:

17.46

Volume:

10.7M

Beta:

1.05

Technical Analysis

SMA50:

41.95

SMA100:

66.56

SMA200:

94.84

52-Wk Change:

-88.95%

Stock Predictions

Is Sarepta Therapeutics stock public?

Yes, Sarepta Therapeutics is a publicly traded company.
What is the Sarepta Therapeutics stock quote today?

The Sarepta Therapeutics stock price is 17.46 USD today.
How to buy Sarepta Therapeutics stock online?

You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jun-5	39.54	39.21	40.49	37.91
Jun-6	40.45	43.01	43.54	40.45
Jun-9	43.80	39.71	43.92	39.41
Jun-10	40.00	39.07	40.90	38.95
Jun-11	39.31	37.81	39.64	37.76
Jun-12	37.60	37.31	37.84	36.80
Jun-13	37.05	36.18	38.09	35.77
Jun-16	21.26	20.94	21.55	18.30
Jun-17	21.16	21.56	22.98	20.51
Jun-18	21.17	20.77	22.10	20.51
Jun-20	20.88	20.08	20.88	19.71
Jun-23	19.76	18.87	19.76	18.70
Jun-24	19.14	18.98	19.43	18.68
Jun-25	18.88	17.46	18.88	17.00

Sarepta Therapeutics Earnings

Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sarepta Therapeutics Forecast Revenue Growth

Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.86 per share, a decrease this year of $5.90 per share, and an increase next year of $5.54 per share.

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.